Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (451-460 of 683) with videos related to

Pageof 69
Sort By:
Antibiotics (Basel, Switzerland)|July 2, 2021
Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial DosingUte Chiriac, Daniel C Richter, Otto R Frey, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care UnitMohd H Abdul-Aziz, Azrin N Abd Rahman, Mohd-Basri Mat-Nor, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2026
A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patientsCaroline Briquet, Perrin Ngougni Pokem, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
New Regimen for Continuous Infusion of Vancomycin in Critically Ill PatientsStefano Cristallini, Maya Hites, Hakim Kabtouri, et al.
European Journal of Clinical Pharmacology|December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignanciesFekade Bruck Sime, Michael S Roberts, Ing Soo Tiong, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2020
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm ModelHajira Bilal, Phillip J Bergen, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2015
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsisClaire Roger, Bastian Nucci, Benjamin Louart, et al.
British Journal of Clinical Pharmacology|July 7, 2026
Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteersAmy Legg, Alison Boast, Kim Piera, et al.
Pageof 69

Showing results (451-460 of 683) with videos related to

Sort By:
Pageof 69
Antibiotics (Basel, Switzerland)|July 2, 2021
Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial DosingUte Chiriac, Daniel C Richter, Otto R Frey, et al.
Antimicrobial Agents and Chemotherapy|October 21, 2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care UnitMohd H Abdul-Aziz, Azrin N Abd Rahman, Mohd-Basri Mat-Nor, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2026
A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patientsCaroline Briquet, Perrin Ngougni Pokem, Xin Liu, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
New Regimen for Continuous Infusion of Vancomycin in Critically Ill PatientsStefano Cristallini, Maya Hites, Hakim Kabtouri, et al.
European Journal of Clinical Pharmacology|December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignanciesFekade Bruck Sime, Michael S Roberts, Ing Soo Tiong, et al.
Antimicrobial Agents and Chemotherapy|May 6, 2020
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm ModelHajira Bilal, Phillip J Bergen, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
<i>Ex Vivo</i> Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamFekade B Sime, Saurabh Pandey, Nermin Karamujic, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2015
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsisClaire Roger, Bastian Nucci, Benjamin Louart, et al.
British Journal of Clinical Pharmacology|July 7, 2026
Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteersAmy Legg, Alison Boast, Kim Piera, et al.
Pageof 69